缬沙坦氨氯地平单片复方制剂对单药治疗血压控制不良的中国高血压患者疗效及安全性研究Ⅱ:原理和设计

被引：16

作者：

胡大一

机构：

[1] 北京大学人民医院心脏中心

来源：

中华高血压杂志 | 2010年 / 18卷 / 12期

关键词：

D O I：

10.16439/j.cnki.1673-7245.2010.12.028

中图分类号：

R544.1 [高血压];

学科分类号：

100201 [内科学];

摘要：

<正>高血压患病率在全球范围内呈上升趋势。在世界范围内,2000年有26.4%的成年人患有高血压,预计2025年总患病率将达到29.2%[1]。2002年中国居民营养与健康状况调查显示,中国15岁及以上人群高血压患病率为18.8%,较1991年增加31%,按患病率估计,中国高血压现患人数约为2亿。据2002年调查,中国人群高血压知晓率为30.6%,治疗率为24.7%,控制率为6.1%,接受治疗的患者的控制率为25%[2]。

引用

收藏

页码：1116 / 1119

页数：4

相关论文

共 11 条

[1]

Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial [J].

Bakris, George L. ;

Sarafidis, Pantelis A. ;

Weir, Matthew R. ;

Dahlof, Bjorn ;

Pitt, Bertram ;

Jamerson, Kenneth ;

Velazquez, Eric J. ;

Staikos-Byrne, Linda ;

Kelly, Roxzana Y. ;

Shi, Victor ;

Chiang, Yann-Tong ;

Weber, Michael A. .

LANCET, 2010, 375 (9721) :1173-1181

[2]

Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients [J].

Jamerson, Kenneth ;

Weber, Michael A. ;

Bakris, George L. ;

Dahlof, Bjorn ;

Pitt, Bertram ;

Shi, Victor ;

Hester, Allen ;

Gupte, Jitendra ;

Gatlin, Marjorie ;

Velazquez, Eric J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (23) :2417-2428

[3]

Efficacy and safety of amlodipine/valsartan compared with amlodipine monotherapy in patients with stage 2 hypertension: a randomized, double-blind, multicenter study: the EX-EFFeCTS Study [J].

Destro, Maurizio ;

Luckow, Anders ;

Samson, Mercedes ;

Kandra, Albert ;

Brunel, Patrick .

JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2008, 2 (04) :294-302

[4]

Global burden of hypertension: analysis of worldwide data [J].

Kearney, PM ;

Whelton, M ;

Reynolds, K ;

Muntner, P ;

Whelton, PK ;

He, J .

LANCET, 2005, 365 (9455) :217-223

[5]

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial [J].

Julius, S ;

Kjeldsen, SE ;

Weber, M ;

Brunner, HR ;

Ekman, S ;

Hansson, L ;

Hua, TS ;

Laragh, J ;

McInnes, GT ;

Mitchell, L ;

Plat, F ;

Schork, A ;

Smith, B ;

Zanchetti, A .

LANCET, 2004, 363 (9426) :2022-2031

[6]

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol [J].

Dahlöf, B ;

Devereux, RB ;

Kjeldsen, SE ;

Julius, S ;

Beevers, G ;

de Faire, U ;

Fyhrquist, F ;

Ibsen, H ;

Kristiansson, K ;

Lederballe-Pedersen, O ;

Lindholm, LH ;

Nieminen, MS ;

Omvik, P ;

Oparil, S ;

Wedel, H .

LANCET, 2002, 359 (9311) :995-1003

[7]

Selected major risk factors and global and regional burden of disease [J].

Ezzati, M ;

Lopez, AD ;

Rodgers, A ;

Vander Hoorn, S ;

Murray, CJL .

LANCET, 2002, 360 (9343) :1347-1360

[8]

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension:: principal results of the hypertension optimal treatment (HOT) randomised trial [J].

Hansson, L ;

Zanchetti, A ;

Carruthers, SG ;

Dahlöf, B ;

Elmfeldt, D ;

Julius, S ;

Ménard, J ;

Rahn, KH ;

Wedel, H ;

Westerling, S .

LANCET, 1998, 351 (9118) :1755-1762

[9]

中国门诊高血压患者治疗现状登记研究.[J].胡大一;刘力生;余金明;姚崇华;.中华心血管病杂志.2010, 03

[10]

氨氯地平-缬沙坦复合片的药物经济学研究 [J].

张崖冰 ;

胡善联 ;

宋哲意 ;

陶立波 .

中国新药与临床杂志, 2010, 29 (02) :143-147